Tango Therapeutics

TNGX

NASDAQHealth Care

Income Statement

Total Revenue$42.07M

Gross Profit$42.07M

Operating Income$-145.6M

EBITDA$-123.85M

EBIT$-130.09M

Pre-tax Income$-101.59M

Net Income$-130.3M

Cash Equivalent$58.85M

Total Debt$37.55M

Book Value$235.2M

Book Value Per Share2.20

Return on Equity (ROE)-65.00%

Return on Assets (ROA)-41.14%

Return on Invested Capital (ROI)-65.00%

Net Profit Margin-309.02%

Current Ratio7.00

Quick Ratio6.78

Long-Term Debt / Equitynull